Dare Bioscience Inc (DARE)
0.3965
-0.03
(-6.57%)
USD |
NASDAQ |
May 22, 16:00
0.3965
0.00 (0.00%)
After-Hours: 16:31
Dare Bioscience Enterprise Value: 39.27M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 21, 2024 | 39.27M |
May 20, 2024 | 58.04M |
May 17, 2024 | 45.43M |
May 16, 2024 | 40.32M |
May 15, 2024 | 32.76M |
May 14, 2024 | 28.21M |
May 13, 2024 | 28.23M |
May 10, 2024 | 27.60M |
May 09, 2024 | 27.91M |
May 08, 2024 | 27.26M |
May 07, 2024 | 27.55M |
May 06, 2024 | 27.15M |
May 03, 2024 | 27.67M |
May 02, 2024 | 27.75M |
May 01, 2024 | 29.55M |
April 30, 2024 | 27.30M |
April 29, 2024 | 24.72M |
April 26, 2024 | 27.14M |
April 25, 2024 | 25.46M |
April 24, 2024 | 25.14M |
April 23, 2024 | 26.27M |
April 22, 2024 | 26.07M |
April 19, 2024 | 24.53M |
April 18, 2024 | 26.05M |
April 17, 2024 | 24.80M |
Date | Value |
---|---|
April 16, 2024 | 45.14M |
April 15, 2024 | 44.66M |
April 12, 2024 | 43.58M |
April 11, 2024 | 44.85M |
April 10, 2024 | 44.51M |
April 09, 2024 | 43.74M |
April 08, 2024 | 46.59M |
April 05, 2024 | 45.78M |
April 04, 2024 | 47.57M |
April 03, 2024 | 44.80M |
April 02, 2024 | 45.90M |
April 01, 2024 | 46.17M |
March 31, 2024 | 45.67M |
March 28, 2024 | 38.83M |
March 27, 2024 | 44.74M |
March 26, 2024 | 39.34M |
March 25, 2024 | 41.01M |
March 22, 2024 | 37.35M |
March 21, 2024 | 37.01M |
March 20, 2024 | 35.80M |
March 19, 2024 | 40.51M |
March 18, 2024 | 40.51M |
March 15, 2024 | 36.35M |
March 14, 2024 | 35.03M |
March 13, 2024 | 35.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.754M
Minimum
Aug 07 2019
123.77M
Maximum
Jan 03 2022
47.71M
Average
45.47M
Median
Enterprise Value Benchmarks
Altimmune Inc | 363.92M |
Verastem Inc | 257.49M |
Oragenics Inc | 13.27M |
Actinium Pharmaceuticals Inc | 179.82M |
Orgenesis Inc | 38.97M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -6.755M |
Revenue (Quarterly) | 0.0093M |
Total Expenses (Quarterly) | 6.032M |
EPS Diluted (Quarterly) | -0.07 |
Profit Margin (Quarterly) | -72.62K% |
Earnings Yield | -80.71% |
Normalized Earnings Yield | -80.71 |